Nuvaira Stock
Develops devices for treating lung diseases
Sign up today and learn more about Nuvaira Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Nuvaira Stock
Nuvaira, Inc. (formerly Holaira, Inc.), located in Minneapolis, Minnesota is a privately held lung denervation company developing minimally invasive products that aims to make breathing easier for patients suffering from obstructive lung diseases.
Funding History
September 2010 | $3.0M |
---|---|
May 2011 | $5.0M |
September 2012 | $10.6M |
February 2013 | $10.0M |
April 2014 | $40.0M |
February 2019 | $79.0M |
Management
President and CEO
Dennis Wahr
Founder & CTO
Martin L. Mayse
Director of Regulatory Affairs
Mahtab Fatemi
Vice President Clinical Affairs
Jim Pavliska
CFO
Kari Kubesh
Senior Vice President Operations
Steve Mertens
Board of Directors, President and CEO
Dennis W. Wahr
Vice President International Development
Scott Grant
Press
thelancet - Dec, 23 2023
Patterns of care in the management of high-risk COPD in the ...bizjournals - Dec, 23 2023
Why this HR expert says intentional listening is key for ...medicaldevice-network - Dec, 23 2023
Leading innovators in minimally invasive surgical instruments ...bizjournals - Dec, 7 2023
Lung device maker Nuvaira raises $15 millionbiospace - Aug, 12 2021
Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone